FDA Issues New Vision-Loss Warning for GLP-1 Drugs. Is Your Practice Ready?
FDA Safety Alert | Physician Practice Intelligence | November 12, 2026 NEW FDA WARNING. A NEW QUESTION FOR EVERY GLP-1 PRESCRIBING PRACTICE. On November 9, the FDA required a classwide labeling warning about a potential rare, serious eye condition. The immediate challenge for clinicians: turn a safety notice into a reliable patient-care workflow. Take the…
